Understanding vaccine hesitancy in a post-factual era

Similar documents
Presentation to Workshop on Enhancing Communication around Influenza Vaccination Susan Goldstein June 2013

Vaccine Hesitancy: an international perspective

Vaccine Hesitancy a widespread problem. Increasing vaccination uptake ECDC communication materials and pilot projects

The challenge of vaccine hesitancy in the European Union

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

Vaccination glossary. Vaccine

Conclusions of the high level hearing on seasonal influenza 30 April 2015, Luxembourg Michael Sulzner

Theo Brandt and Jenny Royle

Vaccine hesitancy in the EU: state of play and impact on vaccination programmes

Vaccine Hesitancy. Michelle P. Medina, MD, FAAP Interim Chair, Department of Community and General Pediatrics, Cleveland Clinic Childrens

Consultation on Strengthened EU cooperation against vaccine preventable diseases

Creating the change. Homeless Link s strategy to end homelessness. June 2018 to June 2021

Changing the prevention paradigm for the future what Europe can do

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

TELL ME Communication Kit

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016

Immunization in the context of adolescent health

Vaccine Hesitancy, Social Media and the HPV vaccine

Affecting Change... Public affairs, campaigning & political. Caroline Collins, PhD Public Affairs Manager The Alzheimer Society of Ireland March 2012

GAVI Alliance Demand-side Innovation Policies

Health in All Policies approach in addressing the Social Determinants of Health and Health Equity - experiences from Finland

Summary Report EU Health Award 2017

PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH

Updates from the European Centre for Disease Prevention and Control

LOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions

Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed

Health Literacy - creating Trust in Vaccination

Joint ICTP-IAEA School on Nuclear Energy Management. 15 July - 3 August, Main Principles of Effective Stakeholder Involvement

NICE guidelines. Flu vaccination: increasing uptake in clinical risk groups and health and social care workers

Vaccine Hesitancy: Acceptance and demand of vaccines in the Americas

Communicating risk. Dr Gaya M Gamhewage. TITLE from VIEW and SLIDE MASTER December 10, 2013

Strategies to address vaccine hesitancy:

CARE S PERSPECTIVE ON THE MDGs Building on success to accelerate progress towards 2015 MDG Summit, September 2010

APPROVAL PROCESS 1.0 Approved by: Joint GAVI Alliance & Fund Board

Contextual overview with reference to MDG Goal 6 and projection for Post-2015

Dr Louise Doherty Immunisation Conference 11th May 2016

Strategic Partnership of UN Women Republic of Moldova Accelerate. Empower. Sustain

WHO GLOBAL ACTION PLAN FOR INFLUENZA VACCINES

Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective

Speech by HRH Crown Princess Mary at WHO s 62nd Regional Committee Malta, September 10, 2012

STRATEGIC PLAN

LIFE-COURSE IMMUNISATION

Measuring and monitoring vaccine confidence

Embedding co-production in mental health: A framework for strategic leads, commissioners and managers

A multi-stakeholder partnership initiative. 10 February 2012

You said we did. Our Healthier South East London. Dedicated engagement events

TB/HIV Care s Experience Setting up PrEP Sites and Engaging Potential Service Users. John Mutsambi and Peggy Modikoe TB/HIV Care

Gavi Risk Appetite Statement Version 2.0

Addressing Complacency, Convenience and Confidence

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

Results Based Advocacy to Increase Access Marie Stopes International

15571/17 YML/ik 1 DG C 1

SPOTLIGHT for policy-making

Advocates Rights Actors Justice for

OHSU Knight Community Partnership Program

University of Kentucky College of Social Work Field Placement Student Self- Evaluation Form Community and Social Development (CSD) Concentration

V A C C I N E H E S I TA N C Y :

The National Framework for Gynaecological Cancer Control

Horizon Introduction. Alex Harris Medical Research Council

TB/HIV policy monitoring & advocacy - an HIV institutional perspective. Alasdair Reid

JOB DESCRIPTION. Senior Media and Communications Officer. Date Prepared: January 2017 PURPOSE

Gavi Alliance Strategy : Goal level indicators and disease dashboard

GAVI, THE VACCINE ALLIANCE

Request for Proposals: Consultancy Evaluation, Toolkits and Economic Impact of the 22nd International AIDS Conference

Pandemic lessons learnt

Resourced civil society organisations should work hand-in-hand with the government to move to the grassroots.

Legislative Approaches to Immunization Across the European Region

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008

II. Transforming the Future through Dynamic Targeted Initiatives Reframing: Effective Communication for Creating Change

The Life Course Immunisation Initiative

An Active Inclusive Capital. A Strategic Plan of Action for Disability in London

STRATEGIC PLAN

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

Tobacco control and the FCTC: Is the EU important at national level and in Sweden?

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

Foundation Competencies CHILD WELFARE EPAS Core

COMMISSION OF THE EUROPEAN COMMUNITIES

Report of an expert panel discussion on: The Future of Vaccines: The Next Decade

Scoping exercise to inform the development of an education strategy for Children s Hospices Across Scotland (CHAS) SUMMARY DOCUMENT

Recommendation 2: Voluntary groups should be supported to build their capacity to promote mental health among their client groups.

Challenges and solutions in making evidence-based national vaccination policies and recommendations

Eurasian Harm Reduction Association (EHRA) Strategic Framework

Papua Maternal, Newborn and Child Health and Nutrition Project

Gender Mainstreaming in the Convention on Biological Diversity

SOS Children s Villages International Child Safety and Corruption Prevention

World Hepatitis Alliance Strategic Plan 2015

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA

at a glance

COMMUNITY. Young Sex Workers

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD

Moving towards 2020 priorities for Public Health for the years Health and Consumers

The perceived full public health value of vaccines and vaccine hesitancy among patients and providers. Pauline Paterson

DEVELOPING A GLOBAL IMMUNIZATION STRATEGY

Monitoring of the achievement of the health-related Millennium Development Goals

FPA Strategic Plan

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

Targeted interventions for asylum seeking and refugee young carers and their families

Transcription:

Understanding vaccine hesitancy in a post-factual era Jonas Sivelä, Senior Researcher, PhD Infectious Disease Control and Vaccinations The Department of Health Security National Institute for Health and Welfare, Finland (THL) 5.10.2017 Jonas Sivelä 1

6.10.2017 Jonas Sivelä 2

Vaccine Hesitancy a complex issue CONTEXTUAL FACTORS Politics Culture Socio-economic Media environment Influential leaders INDIVIDUAL/GROUP FACTORS Social norms Beliefs Attitudes / Motivation Knowledge Personal experience VACCINE/VACCINATION SPECIFIC ISSUES Schedule Delivery Costs Introduction of new vaccines 6.10.2017 Esityksen nimi / Tekijä 3

Vaccine hesitancy definition Strategic Advisory Group of Experts (SAGE) on Immunisation: Vaccine hesitancy refers to delay in acceptance or refusal of vaccines despite availability of vaccine services. Vaccine hesitancy is complex and context specific, varying across time, place and vaccines. It is influenced by a number of factors including issues of confidence, complacency, and convenience Complacency When perceived risks of vaccine preventable diseases are low and when vaccination is not considered a necessary preventive action. Convenience When the quality and degree of service affects the decision to vaccinate. Confidence When the trust in the effectiveness and safety of vaccines and in the system that delivers them affects the decision to vaccinate. MacDonald, NE. & The SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine (2015), Volume 33, Issue 34, 14, 4161 4164. 6.10.2017 Jonas Sivelä 4

Historical perspective Anti-vaccination lobbies since the early smallpox immunizations during the 19th century Anti-Vaccination Society of America (1879) Anti-Compulsory Vaccination League (1882) Resist the forcing of dead corruption into the blood of children. Homer Bartlett Wilson It is no longer medicine but for the most part destruction. William Young 6.10.2017 Jonas Sivelä 5

Post-truth world, alternative facts, conspiracy theories 6.10.2017 Jonas Sivelä 6

Areas of development Strengthen the role and of healthcare workers as effective advocates of vaccination, including pre- and in-service training; develop tools for encountering vaccine hesitant clients. Raise awareness about vaccines and vaccinations; to increase trust in the decision-making process and in scientific evidence. Put more focus on acces issues. Invest in evaluation of activities both ex-ante (listening/understanding real concerns) and expost (many activities but how effective are they). Engage with grassroots levels and civil society in order to enhance understanding (incl. patient groups, disease-based organisations). Develop cooperation between different initiatives, projects, programmes addressing vaccine hesitancy. 6.10.2017 Jonas Sivelä 7

However Developing and implementing context-specific interventions requires a lot of resources. Many inspiring studies and initiatives exist, but how do we translate these into sustainable, longterm solutions? The majority of people vaccinate themselves we need also to focus on what we do well where we succeed and why! And, in order to make use of everything we do, we still need: Well organized and functioning national immunization programs 6.10.2017 Jonas Sivelä 8

Thank you! 6.10.2017 Jonas Sivelä 9

EU Joint Action on Vaccination WP 8: Vaccine hesitancy and uptake. From research and practices to implementation To develop a systematic overview and analysis of best practices, lessons learned and experiences of implementing into action research based knowledge concerning vaccine hesitancy and confidence in: Member States, among stakeholders and partners, in the research community, and among policy makers. To develop mechanisms and tools for disseminating best practices, lessons learned and research-based knowledge and throughout Member States. To identify sentiments and opinions of public on vaccine confidence and hesitancy, and develop tools used to monitor these. 6.10.2017 Jonas Sivelä 10